Get the Stockscreener App
4.48
13.71%
0.54
After Hours:
4.50
0.02
+0.45%
Dna X Inc stock is traded at $4.48, with a volume of 80,467.
It is up +13.71% in the last 24 hours and up +7.43% over the past month.
DNA X Inc is engaged in providing crypto trading services through its online platform, enabling users to buy, sell, and exchange cryptocurrencies, as well as execute automated trading strategies between currency pairs. The company generates revenue from commissions and fees on trading activity.
See More
Previous Close:
$3.94
Open:
$4.02
24h Volume:
80,467
Relative Volume:
1.93
Market Cap:
$6.67M
Revenue:
$59.11M
Net Income/Loss:
$-33.38M
P/E Ratio:
-0.025
EPS:
-178.995
Net Cash Flow:
$-26.04M
1W Performance:
-6.10%
1M Performance:
+7.43%
6M Performance:
-36.72%
1Y Performance:
-74.63%
1-Day Range:
$4.02
$4.87
1-Week Range:
$3.4791
$5.02
52-Week Range:
$2.5211
$38.52
Dna X Inc Stock (SONM) Company Profile
Name
Dna X Inc
Sector
Industry
Phone
650-378-8100
Address
4445 EASTGATE MALL, SAN DIEGO, TX
Compare SONM vs MSFT, ORCL, PLTR, CRWD, SNPS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SONM
Dna X Inc
|
4.48 | 5.86M | 59.11M | -33.38M | -26.04M | -179.00 |
MSFT
Microsoft Corp
|
418.57 | 3.11T | 318.27B | 125.22B | 72.92B | 16.79 |
ORCL
Oracle Corp
|
192.08 | 545.79B | 64.08B | 16.40B | -24.74B | 5.5698 |
PLTR
Palantir Technologies Inc
|
136.88 | 329.43B | 5.22B | 2.29B | 2.69B | 0.8876 |
CRWD
Crowdstrike Holdings Inc
|
663.46 | 165.00B | 4.81B | -181.85M | 1.24B | -0.7398 |
SNPS
Synopsys Inc
|
524.74 | 96.54B | 8.00B | 1.10B | 2.28B | 6.4708 |
Dna X Inc Stock (SONM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-18-19 | Initiated | B. Riley FBR | Buy |
| Jul-09-19 | Upgrade | National Securities | Neutral → Buy |
| Jun-10-19 | Initiated | National Securities | Neutral |
| Jun-04-19 | Initiated | Lake Street | Buy |
| Jun-04-19 | Initiated | Oppenheimer | Outperform |
View All
Dna X Inc Stock (SONM) Latest News
DNA X Inc. (SONM) Q3 2024 Earnings: EPS Beats Estimates, Stock Surges 13.71%Community Hot Stocks - Newser
DNA X Inc. (SONM) Surges 13% as Buyer Demand Tests Key Resistance at $4.68Institutional Grade Picks - Newser
Ginkgo Bioworks Holdings Inc (DNA): What’s the Future of Autonomous Lab? - Yahoo Finance Singapore
12 Information Technology Stocks Moving In Thursday's Intraday SessionAmplitech Group, Inc.Series A - Benzinga
DNA X, Inc. (SONM) Reports Q1 2026 Financial Results, Completes Mobile Business Sale, and Focuses on AI Crypto Trading Platform - Minichart
DNA X, Inc. Reports First Quarter 2026 Financial Results - Scott Coop
DNA X: Q1 Earnings Snapshot - kare11.com
DNA X, Inc. 1Q 2026: Revenue $0 Net income $6.34M, EPS $5.01— 10-Q Summary - TradingView
SONM: Q1 2026 net income surged to $6.3M on asset sale, but core crypto trading posted a $3.9M loss - TradingView
DNA X, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
DNA X (NASDAQ: SONM) exits handset business, leans on crypto platform and new funding - Stock Titan
SONM: Exited legacy business, posted strong net income, and pivoted to AI crypto trading platform - TradingView
DNA X (NASDAQ: SONM) exits phones, pivots to AI crypto trading - Stock Titan
FMAC Price Today: Future Money Acquisition Corporation Stock Price, Quote & Chart | MEXC - MEXC Exchange
AUC Price Today: ATIF Holdings Limited Stock Price, Quote & Chart | MEXC - MEXC
Stock Market News for May 20, 2026 - Stock Titan
Why Is DNA Brands, Inc. (DNAX) Stock Down Today? - Meyka
SONM Stock Price, Quote & Chart | DNA X INC (NASDAQ:SONM) - ChartMill
DNA X, Inc. Delays Quarterly Filing After Asset Sale - TipRanks
12 Information Technology Stocks Moving In Friday's After-Market Session - Benzinga
DNA X (SONM) delays Q1 2026 10-Q after Legacy Business sale; expects $3.6M loss - Stock Titan
Dna Brands Inc (OP: DNAX - The Chronicle-Journal
DNA X (SONM): Laurence Lytton discloses 120,357 shares (8.1%) - Stock Titan
How DNA's Double Helix Structure Was Discovered - Britannica
Takara Bio Inc stock (JP3463000004): Featured in expanding DNA polymerase and cell culture media mar - AD HOC NEWS
Lotus unveils Focus 2030 strategy with new hybrid-V8 supercar and X-Hybrid tech for global growth. - Pluang
Lotus Unveils Focus 2030Reinforcing Brand DNA with an All-New Hybrid-V8 Supercar - The Manila Times
Lotus Unveils Focus 2030 – Reinforcing Brand DNA with an All-New Hybrid-V8 Supercar - mykxlg.com
About Us | Oil & Gas JournalLotus Unveils Focus 2030 – Reinforcing Brand DNA with an All-New Hybrid-V8 Supercar - FinancialContent
DNA X Inc. (SONM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Price, News, Quote & History - Yahoo Finance
[8-K] Ginkgo Bioworks Holdings, Inc. Reports Material Event - Stock Titan
Central Bancompany, Inc. Announces Dividend Declaration and Reports May 2026 SEC Filing Results - Minichart
What DNA X (SONM) subscription metrics reveal about retention | Q3 2024: Profit Exceeds ViewsBuy Rating - newser.com
SONM | DNA X, Inc. Common Insider Trading - Quiver Quantitative
SONM Forecast, Price Target & Analyst Ratings | DNA X INC (NASDAQ:SONM) - ChartMill
[10-K/A] DNA X, Inc. Amends Annual Report - Stock Titan
[8-K] DNA X, Inc. Reports Material Event - Stock Titan
Ginkgo Bioworks will take investor questions after May 7 results - Stock Titan
Ansa Biotechnologies to Showcase Breakthrough DNA Synthesis Technology Backed by Industry’s Only On-Time Guarantee at SynBioBeta 2026 Conference - 01net
Profluent Announces Strategic Partnership with Lilly to Develop AI-Designed Recombinases for Genetic Medicine - Business Wire
SONM Price Today: DNA X, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
SONM (DNA X) reports narrower than projected Q3 2024 loss, with shares rising 7.75 percent in today’s session.Viral Momentum Stocks - newser.com
INSP (Inspire Medical Systems Inc.) Q4 2025 EPS beats estimates by wide margin even as shares dip slightly today. - Cổng thông tin điện tử tỉnh Lào Cai
SONM (DNA X) tops Q3 2024 EPS forecasts, lifting shares nearly 10 percent on positive investor sentiment.Management Guidance - Cổng thông tin điện tử tỉnh Lào Cai
SONM SEC FilingsDNA X 10-K, 10-Q, 8-K Forms - Stock Titan
Sonim Technologies Public Entity Rebrands As DNA X, Inc., A Digital Asset Management Company - 富途牛牛
DNA X, Inc. Reports 2025 Financial Results, Completes Asset Sale, and Focuses on Growth of Cryptocurrency Trading Platform - Minichart
12 Information Technology Stocks Moving In Wednesday's After-Market Session - Benzinga
DNA X, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
DNA X (NASDAQ: SONM) outlines crypto shift, tiny scale and going‑concern risk - Stock Titan
Dna X Inc Stock (SONM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.83%
1.66%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):